the latest EMCDDA work programme, which outlines our activities for 2023–2025
Archives for February 2023
Bibliography: All Publications
How England is eliminating hepatitis C
This report explores the development of the programme, how several of the key initiatives have worked and developed over time, and next steps in the programme (HCV Action)
Synthetic opioids will be banned as government acts to stop drug deaths
Eleven more lethal substances to be made Class A drugs, following a recommendation by the Advisory Council on the Misuse of Drugs (Home Office)
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions (Australian Government)
Hepatitis C in the UK 2023
Working to eliminate hepatitis C as a public health threat (Health Security Agency)
Substance misuse treatment for young people: statistics 2021 to 2022
Alcohol and drug treatment data for young people under 18, from the National Drug Treatment Monitoring System (Office for Health Improvement and Disparities)
Impact of the California Harm Reduction Initiative
RTI’s National Survey of Syringe Service Programs (SSPs) showed that California’s investment in harm reduction yielded high levels of life-saving interventions in its three years of existence
